PRA Health Sciences PE Ratio 2013-2018 | PRAH

Current and historical PE ratio for PRA Health Sciences (PRAH) from 2013 to 2018. The price to earnings or PE ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. The current PE ratio for PRA Health Sciences (PRAH) as of March 31, 2018 is 30.66.
Sector Industry Market Cap Revenue
Medical Medical Services $0.008B $2.259B
PRA Health Sciences, Inc. operates as a global contract research organizations providing outsourced clinical development services to the biotechnology and pharmaceutical industries. It offers therapeutic services in the areas of cardio-metabolic, biosimilars, infectious diseases, immunology, neurology and psychiatry, oncology and hematology, rare diseases, and respiratory needs. The Company engages in bioanalytical laboratory, clinical pharmacology, clinical development, strategic solutions, post marketing research, clinical informatics, clinical diagnostics, and safety and risk management activities. PRA Health Sciences, Inc. is based in Raleigh, North Carolina.
Stock Name Country Market Cap PE Ratio
Express Scripts Holding (ESRX) United States $45.769B 10.78
ICON (ICLR) Ireland $7.482B 25.11
Charles River Laboratories (CRL) United States $5.621B 21.85
INC Research Holdings (SYNH) United States $5.077B 22.35
Premier (PINC) United States $4.995B 20.20
HealthEquity (HQY) United States $4.978B 105.57
Teladoc (TDOC) United States $4.120B 0.00
NovoCure (NVCR) Jersey $3.002B 0.00
AMN Healthcare Services Inc (AMN) United States $2.850B 21.73
Intrexon (XON) United States $1.989B 0.00
BioTelemetry (BEAT) United States $1.615B 44.77
Medpace Holdings (MEDP) United States $1.589B 25.27
Healthways (TVTY) United States $1.449B 20.54
IKang Healthcare (KANG) China $1.419B 78.62
Natera (NTRA) United States $1.177B 0.00
China Cord Blood (CO) China $0.971B 25.97
Apollo Medical Holdings (AMEH) United States $0.777B 0.00
Surgery Partners (SGRY) United States $0.748B 0.00
Civitas Solutions (CIVI) United States $0.600B 15.28
CareDx (CDNA) United States $0.437B 0.00
OncoCyte (OCX) United States $0.124B 0.00
Interpace Diagnostics (IDXG) United States $0.026B 0.00
Cancer Genetics (CGIX) United States $0.024B 0.00
Biocept (BIOC) United States $0.016B 0.00
OpGen (OPGN) United States $0.012B 0.00
FORM Holdings (XSPA) United States $0.008B 0.00